Profile
Tess Cameron is a Principal, Strategic Finance at RA Capital Management.
Tess’s primary responsibility is to partner with our portfolio companies as a strategic finance advisor.
Tess comes to RA from Foghorn Therapeutics, where she was Head of Finance.
Prior to Foghorn, Tess held finance leadership roles at Wave Life Sciences, where she was responsible for FP&A and corporate finance, and Biogen, where she was the finance lead for the CMO and the neurodegeneration portfolio.
Prior to joining biotech/pharma, she was a specialist in the corporate finance team at McKinsey &Co, focused on corporate transactions.
Tess has a BA with a double major in Economics and Peace & Conflict studies from the University of Toronto, Canada.
Tess Cameron active positions
| Companies | Position | Start |
|---|---|---|
| RESEARCH ALLIANCE CORP. II | Director of Finance/CFO | 17/07/2020 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Corporate Officer/Principal | 01/06/2020 |
Avilar Therapeutics, Inc.
Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases | Director/Board Member | 01/10/2020 |
Medical Microinstruments SpA
Medical Microinstruments SpA Medical SpecialtiesHealth Technology Develops and manufactures surgical micro-instruments | Director/Board Member | 20/07/2022 |
Nodexus, Inc.
Nodexus, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company which commercializing the one platform to address widespread unmet needs | Director/Board Member | - |
Research Alliance Holdings II LLC | Corporate Officer/Principal | - |
Former positions of Tess Cameron
| Companies | Position | End |
|---|---|---|
| CYTEK BIOSCIENCES, INC. | Director/Board Member | 01/06/2022 |
| FOGHORN THERAPEUTICS INC. | Corporate Officer/Principal | 01/06/2020 |
| WAVE LIFE SCIENCES LTD. | Director/Board Member | 01/01/2018 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Tess Cameron
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Wave Life Sciences Ltd.
Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytek Biosciences, Inc.
Cytek Biosciences, Inc. Medical SpecialtiesHealth Technology Operates as a life sciences technology company engages in the provision of cell analysis tools by leveraging novel technical approaches | Health Technology |
Foghorn Therapeutics, Inc.
Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Medical Microinstruments SpA
Medical Microinstruments SpA Medical SpecialtiesHealth Technology Develops and manufactures surgical micro-instruments | Health Technology |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Finance |
Nodexus, Inc.
Nodexus, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company which commercializing the one platform to address widespread unmet needs | Commercial Services |
Avilar Therapeutics, Inc.
Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases | Commercial Services |
Research Alliance Corp. II
Research Alliance Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Research Alliance Holdings II LLC |
- Stock Market
- Insiders
- Tess Cameron
















